2-(o-aminophenethyl)-1-methylpiperidine hydroiodide | 210282-36-3

• 分子结构分类: 有机化合物 - 生物碱及其衍生物
• 英文名称: 2-(o-aminophenethyl)-1-methylpiperidine hydroiodide
• 英文别名: (RS)-2-(o-aminophenethyl)-1-methylpiperidine hydroiodide
• CAS: 210282-36-3
• 化学式: C₁₄H₂₂N₂*HI
• 分子量: 346.255
• InChiKey: CJLGKKLMKRLRLS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  17.0
• 可旋转键数：
  3.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  29.26
• 氢给体数：
  1.0
• 氢受体数：
  2.0

反应信息

• 作为反应物：
  描述：

  2-(o-aminophenethyl)-1-methylpiperidine hydroiodide 在 碳酸氢钠 、 potassium carbonate 、 sodium hydroxide 作用下， 以 MeOH 、 醋酸异丙酯 、 乙酸乙酯 为溶剂， 反应 2.0h， 生成 Iferanserin
  参考文献：
  名称：

  Development of a Scalable Synthesis of a Serotonin Receptor Antagonist

  摘要：

  An efficient process was developed for the manufacture of MSA100, a serotonin receptor antagonist, via a five-step synthetic route furnishing a high quality of active pharmaceutical ingredient. Highlights of this synthesis include: (1) replacing carcinogenic methyl iodide with methyl p-toluenesulfonate as the methylating reagent; (2) a hydrogenation protocol with optimized temperature, pressure, and mass-transfer conditions that avoided one side product and reduced the other one effectively; (3) chemical resolution employing D-camphoric acid in a mixed-solvent system; (4) amidation under anhydrous conditions for controlling a Michael adduct impurity; and (5) plausible mechanisms for the formation of side products.

  DOI：

  10.1021/op5003402
• 作为产物：
  描述：

  (E)-2-(2-nitrostyryl)pyridine 在 platinum on activated charcoal 、 氢气 、 碘甲烷 作用下， 以 甲醇 、 丙酮 为溶剂， 生成 2-(o-aminophenethyl)-1-methylpiperidine hydroiodide
  参考文献：
  名称：

  Development of a Scalable Synthesis of a Serotonin Receptor Antagonist

  摘要：

  An efficient process was developed for the manufacture of MSA100, a serotonin receptor antagonist, via a five-step synthetic route furnishing a high quality of active pharmaceutical ingredient. Highlights of this synthesis include: (1) replacing carcinogenic methyl iodide with methyl p-toluenesulfonate as the methylating reagent; (2) a hydrogenation protocol with optimized temperature, pressure, and mass-transfer conditions that avoided one side product and reduced the other one effectively; (3) chemical resolution employing D-camphoric acid in a mixed-solvent system; (4) amidation under anhydrous conditions for controlling a Michael adduct impurity; and (5) plausible mechanisms for the formation of side products.

  DOI：

  10.1021/op5003402

文献信息

• [EN] METHODS AND COMPOSITIONS FOR TREATING INTERNAL AND EXTERNAL HEMORRHOIDS<br/>[FR] PROCÉDÉS ET COMPOSITIONS POUR TRAITEMENT D'HÉMORROÏDES INTERNES ET EXTERNES
  申请人：SAM AMER & CO INC

  公开号：WO2012026914A1

  公开（公告）日：2012-03-01

  The present invention relates to compositions and methods for treatment of internal and/or external hemorrhoids, wherein the treatment includes topically administering to a subject a composition comprising from 0.3% to 0.7% of S-2'- [2-(l-methyl-2- piperidyl) ethyl] cinnamanilide, wherein the S-2'- [2-(l-methyl-2-piperidyl) ethyl] cinnamanilide not only treats the hemorrhoidal symptoms but delays or inhibits the recurrence of hemorrhoids and/or symptoms thereof.

  本发明涉及用于治疗内部和/或外部痔疮的组合物和方法，其中治疗包括局部给予受试者一种含有0.3%至0.7%的S-2'-[2-(l-甲基-2-哌啶基)乙基]肉桂酰亚胺的组合物，其中S-2'-[2-(l-甲基-2-哌啶基)乙基]肉桂酰亚胺不仅治疗痔疮症状，还延迟或抑制痔疮的复发和/或其症状。
• [EN] METHODS AND COMPOSITIONS FOR TREATING HEMORRHOIDS WHILE PROVIDING LOCAL ANESTHETIC AND ANTI-INFLAMMATORY EFFECTS<br/>[FR] MÉTHODES ET COMPOSITIONS DE TRAITEMENT DES HÉMORROÏDES À EFFETS ANESTHÉSIQUES ET ANTI-INFLAMMATOIRES LOCAUX
  申请人：VENTRUS BIOSCIENCES INC

  公开号：WO2013070236A1

  公开（公告）日：2013-05-16

  The present invention relates to compositions and methods for treatment of internal and/or external hemorrhoids, wherein the treatment includes topically administering to a subject a composition comprising from 0.3% to 0.7% of S-2'- [2-(1-methyl-2- piperidyl) ethyl] cinnamanilide, wherein the S-2'- [2-(1-methyl-2-piperidyl) ethyl] cinnamanilide not only treats the hemorrhoidal symptoms but exhibits a local anesthetic effect while controlling inflammation in the area of treatment.

  本发明涉及用于治疗内部和/或外部痔疮的组合物和方法，其中治疗包括局部给予受试者一种含有0.3％至0.7％的S-2'-[2-(1-甲基-2-哌啶基)乙基]肉桂酰亚胺的组合物，其中S-2'-[2-(1-甲基-2-哌啶基)乙基]肉桂酰亚胺不仅治疗痔疮症状，而且在治疗区域内具有局部麻醉作用，同时控制炎症。